93 related articles for article (PubMed ID: 8924229)
1. Assessment of diagnostic utility of anti-CD34 in soft tissue tumors.
Park HR; Park YK
J Korean Med Sci; 1995 Dec; 10(6):436-41. PubMed ID: 8924229
[TBL] [Abstract][Full Text] [Related]
2. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
3. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions.
Weiss SW; Nickoloff BJ
Am J Surg Pathol; 1993 Oct; 17(10):1039-45. PubMed ID: 7690524
[TBL] [Abstract][Full Text] [Related]
4. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue.
Kutzner H
J Am Acad Dermatol; 1993 Apr; 28(4):613-7. PubMed ID: 7681857
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
6. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.
Suster S; Fisher C; Moran CA
Am J Surg Pathol; 1998 Jul; 22(7):863-72. PubMed ID: 9669348
[TBL] [Abstract][Full Text] [Related]
7. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma.
Lazova R; Moynes R; May D; Scott G
Cancer; 1997 Jun; 79(11):2115-24. PubMed ID: 9179057
[TBL] [Abstract][Full Text] [Related]
8. Fibrohistiocytic lipoma: twelve cases of a previously undescribed benign fatty tumor.
Marshall-Taylor C; Fanburg-Smith JC
Ann Diagn Pathol; 2000 Dec; 4(6):354-60. PubMed ID: 11149965
[TBL] [Abstract][Full Text] [Related]
9. D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Bandarchi B; Ma L; Marginean C; Hafezi S; Zubovits J; Rasty G
Mod Pathol; 2010 Mar; 23(3):434-8. PubMed ID: 20062007
[TBL] [Abstract][Full Text] [Related]
10. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues.
Fanburg-Smith JC; Miettinen M
Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228
[TBL] [Abstract][Full Text] [Related]
11. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors.
Cohen PR; Rapini RP; Farhood AI
J Cutan Pathol; 1993 Feb; 20(1):15-20. PubMed ID: 7682226
[TBL] [Abstract][Full Text] [Related]
12. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
[TBL] [Abstract][Full Text] [Related]
13. Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.
West RB; Harvell J; Linn SC; Liu CL; Prapong W; Hernandez-Boussard T; Montgomery K; Nielsen TO; Rubin BP; Patel R; Goldblum JR; Brown PO; van de Rijn M
Am J Surg Pathol; 2004 Aug; 28(8):1063-9. PubMed ID: 15252314
[TBL] [Abstract][Full Text] [Related]
14. STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics.
Cheah AL; Billings SD; Goldblum JR; Carver P; Tanas MZ; Rubin BP
Pathology; 2014 Aug; 46(5):389-95. PubMed ID: 24977739
[TBL] [Abstract][Full Text] [Related]
15. CA125 expression in epithelioid sarcoma.
Kato H; Hatori M; Kokubun S; Watanabe M; Smith RA; Hotta T; Ogose A; Morita T; Murakami T; Aiba S
Jpn J Clin Oncol; 2004 Mar; 34(3):149-54. PubMed ID: 15078911
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin in relation to growth patterns of fibrohistiocytic tumours--an immunohistochemical study of benign and malignant fibrous histiocytomas.
Stiller D; Bahn H
Acta Histochem; 1987; 82(1):95-108. PubMed ID: 2827424
[TBL] [Abstract][Full Text] [Related]
18. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.
Traweek ST; Kandalaft PL; Mehta P; Battifora H
Am J Clin Pathol; 1991 Jul; 96(1):25-31. PubMed ID: 1712541
[TBL] [Abstract][Full Text] [Related]
19. Vimentin-negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34.
Arber DA; Kandalaft PL; Mehta P; Battifora H
Am J Surg Pathol; 1993 Mar; 17(3):302-7. PubMed ID: 7679559
[TBL] [Abstract][Full Text] [Related]
20. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms.
Campbell LK; Thomas JR; Lamps LW; Smoller BR; Folpe AL
Mod Pathol; 2003 Oct; 16(10):963-9. PubMed ID: 14559978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
